Vitaspring Biome (VSBC) Stock Price, News & Analysis
Company Description
Vitaspring Biome (OTC Link: VSBC) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.3M.
VSBC stock has declined 93.8% over the past year.
On a trailing twelve-month basis, Vitaspring Biome reported revenue of $0 with net income of -$415K and diluted earnings per share of $0.00.
This page provides a comprehensive overview of VSBC stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vitaspring Biome (VSBC) stock. Over the past 12 months, the stock has lost 93.8%. At a market capitalization of $2.3M, VSBC is classified as a micro-cap stock with approximately 207.0M shares outstanding.
VSBC Rankings
Latest News
SEC Filings
Vitaspring Biome has filed 5 recent SEC filings, including 3 Form 10-Q, 2 Form 10-K. The most recent filing was submitted on June 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VSBC SEC filings →
Financial Highlights
operating income reached -$385K, and net income was -$415K. Diluted earnings per share stood at $0.00. The company generated -$3K in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
VSBC Company Profile & Sector Positioning
Vitaspring Biome (VSBC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.